A RISK-BENEFIT APPRAISAL OF INJECTABLE NSAIDS IN THE MANAGEMENT OF POSTOPERATIVE PAIN

被引:38
作者
NUUTINEN, LS
LAITINEN, JO
SALOMAKI, TE
机构
[1] Department of Anaesthesiology, University Hospital, Kuopio, SF-70211
[2] Departments of Anaesthesiology, University Hospitals, Oulu
关键词
D O I
10.2165/00002018-199309050-00006
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The inadequacy of pain treatment has been demonstrated in many patient groups suffering from acute pain. The injectable nonsteroidal anti-inflammatory drugs (NSAIDs), including indomethacin, diclofenac, ketoprofen and ketorolac, provide relief from the pain associated with several different conditions. When administered alone or in combination with low doses of opioids, NSAIDs provide good pain relief after musculoskeletal trauma or operation. The main advantage of these agents is that they may form the first-line therapy for pain relief and thus decrease the need of opioids. This avoids respiratory depression which can be associated with opioids. In contrast to opioids, NSAIDs do not cause respiratory depression or have marked adverse effects on the central nervous system. However, they may be associated with adverse effects of the gastrointestinal tract, liver and kidneys, and may increase pre- and postoperative bleeding and cause allergic reactions. These effects are related to the ability of NSAIDs to inhibit prostaglandin synthesis. Use of NSAIDs has to be considered carefully in patients with asthma, allergy to aspirin and NSAIDs, atopy, peptic ulcer or bleeding disorders (such as abnormalities in blood coagulation or coagulation deficits). These considerations are especially important in elderly patients. Having taken these contraindications into account, many clinical studies have demonstrated that NSAIDs are at least as safe as opioids when administered in the short term. However, few studies have specifically monitored adverse effects or included patients over 65 to 70 years of age. In addition, patients with risk factors have often been excluded from the trials. Therefore, the risk-benefit ratio of NSAIDs requires further assessment.
引用
收藏
页码:380 / 393
页数:14
相关论文
共 121 条
[1]  
Aglietti P., Saggini R., Piscini S., Intravenous indoprofen in the prevention of postoperative pain, Current Therapeutic Research, 36, pp. 1235-1241, (1984)
[2]  
Aitken H.A., Burns J.W., McArdle C.S., Kenny N.C., Effects of ketorolac trometamol on renal function, British Journal of Anaesthesia, 68, pp. 481-485, (1992)
[3]  
Allison M.C., Howatson A.G., Torrance C.J., Lee F.D., Russel R.I., Gastrointestinal damage associated with the use of nonsteroidal anti-inflammatory drugs, New England Journal of Medicine, 327, pp. 749-754, (1992)
[4]  
Alvan G., Orme M., Bertilsson R., Ekstrand L., Palmer R., Pharmacokinetics of indomethacin, Clinical Pharmacology and Therapeutics, 18, pp. 364-373, (1976)
[5]  
Bensemana D., Gascon A.L., Relationship between analgesia and turnover of brain biogenetic amines, Canadian Journal of Physiology and Pharmacology, 56, pp. 721-730, (1978)
[6]  
Black A., Taking pains to take away pain, British Medical Journal, 302, pp. 1165-1166, (1991)
[7]  
Blum R.A., Watson W.A., Aging and nonsteroidal anti-inflammatory drug-induced renal dysfunction, DICP: Annals of Pharmacotherapy, 23, pp. 74-75, (1989)
[8]  
Bricker S.R.W., Savage M.E., Hanning C.D., Peri-operative blood loss and non-steroidal anti-inflammatory drugs: an investigation using diclofenac in patients undergoing transurethral resection of the prostate, European Journal of Anaesthesiology, 4, pp. 429-434, (1987)
[9]  
Brown C.R., Moodie J.E., Evans S.A., Clarke P.J., Rotherham B.A., Et al., Efficacy of intramuscular ketorolac and meperidine in pain following major oral surgery, Clinical Pharmacology and Therapeutics, 43, (1988)
[10]  
Brown D.L., Carpenter R.L., Perioperative analgesia: a review of risks and benefits, Journal of Cardiothoracic and Vascular Anesthesia, 4, pp. 368-383, (1990)